Industry Perspective on First-in-Human and Clinical Pharmacology Strategies to Support Clinical Development of T-Cell Engaging Bispecific Antibodies for Cancer Therapy.
Nagaraja Shastri P, Shah N, Lechmann M, Mody H, Retter MW, Zhu M, Li T, Wang J, Shaik N, Zheng X, Ovacik M, Hua F, Jawa V, Boetsch C, Cao Y, Burke J, Datta K, Gadkar K, Upreti V, Betts A.
Nagaraja Shastri P, et al. Among authors: zheng x.
Clin Pharmacol Ther. 2024 Sep 19. doi: 10.1002/cpt.3439. Online ahead of print.
Clin Pharmacol Ther. 2024.
PMID: 39295563
Review.